Drug
Sennosides And Docusate Sodium
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hospice Care | 22 | 16.5 | 16.6 | signal |
| 2 | Dermatitis Contact | 20 | 13.0 | 13.1 | signal |
| 3 | Arteriosclerosis | 11 | 8.6 | 8.6 | signal |
| 4 | Taste Disorder | 23 | 8.5 | 8.5 | signal |
| 5 | Weight Fluctuation | 11 | 7.8 | 7.8 | signal |
| 6 | Skin Laceration | 11 | 7.5 | 7.5 | signal |
| 7 | Infusion Site Pain | 13 | 7.5 | 7.5 | signal |
| 8 | Mental Status Changes | 27 | 7.2 | 7.2 | signal |
| 9 | Incontinence | 10 | 7.0 | 7.0 | signal |
| 10 | Rib Fracture | 19 | 6.8 | 6.9 | signal |
| 11 | Plasma Cell Myeloma | 35 | 6.6 | 6.7 | signal |
| 12 | Blood Count Abnormal | 13 | 6.2 | 6.3 | signal |
| 13 | Blood Sodium Decreased | 15 | 5.9 | 5.9 | signal |
| 14 | Neutrophil Count Increased | 8 | 5.7 | 5.7 | signal |
| 15 | Kidney Infection | 15 | 5.6 | 5.7 | signal |
| 16 | Constipation | 161 | 5.5 | 5.8 | signal |
| 17 | Body Height Decreased | 8 | 5.5 | 5.5 | signal |
| 18 | Pulmonary Thrombosis | 8 | 5.4 | 5.4 | signal |
| 19 | Supraventricular Tachycardia | 7 | 5.4 | 5.4 | signal |
| 20 | Eye Infection | 8 | 5.3 | 5.3 | signal |
| 21 | Musculoskeletal Chest Pain | 11 | 5.2 | 5.2 | signal |
| 22 | Feeding Disorder | 14 | 5.2 | 5.2 | signal |
| 23 | Full Blood Count Decreased | 14 | 5.1 | 5.1 | signal |
| 24 | Blood Potassium Decreased | 20 | 4.9 | 4.9 | signal |
| 25 | Unresponsive To Stimuli | 17 | 4.9 | 4.9 | signal |
| 26 | Sinus Disorder | 13 | 4.8 | 4.8 | signal |
| 27 | Decreased Activity | 7 | 4.8 | 4.8 | signal |
| 28 | Brain Neoplasm | 6 | 4.8 | 4.8 | signal |
| 29 | Small Intestinal Obstruction | 8 | 4.8 | 4.8 | signal |
| 30 | Blood Thyroid Stimulating Hormone Increased | 6 | 4.8 | 4.8 | signal |
| 31 | Intervertebral Disc Degeneration | 6 | 4.8 | 4.8 | signal |
| 32 | Seasonal Allergy | 9 | 4.7 | 4.7 | signal |
| 33 | Blood Urine Present | 12 | 4.6 | 4.7 | signal |
| 34 | Nerve Injury | 7 | 4.6 | 4.6 | signal |
| 35 | Dizziness Postural | 6 | 4.6 | 4.6 | signal |
| 36 | Hernia | 12 | 4.6 | 4.6 | signal |
| 37 | Urinary Tract Infection | 106 | 4.6 | 4.7 | signal |
| 38 | Oral Pain | 14 | 4.6 | 4.6 | signal |
| 39 | Micturition Urgency | 7 | 4.5 | 4.6 | signal |
| 40 | Stomatitis | 37 | 4.5 | 4.5 | signal |
| 41 | Neoplasm | 7 | 4.5 | 4.5 | signal |
| 42 | Insurance Issue | 9 | 4.5 | 4.5 | signal |
| 43 | Dehydration | 80 | 4.4 | 4.5 | signal |
| 44 | Economic Problem | 9 | 4.3 | 4.3 | signal |
| 45 | Poor Venous Access | 6 | 4.3 | 4.3 | signal |
| 46 | Neuropathy Peripheral | 54 | 4.2 | 4.3 | signal |
| 47 | Mass | 8 | 4.2 | 4.2 | signal |
| 48 | Full Blood Count Abnormal | 6 | 4.2 | 4.2 | signal |
| 49 | Retching | 12 | 4.2 | 4.2 | signal |
| 50 | Cystitis | 18 | 4.1 | 4.2 | signal |
| 51 | Platelet Count Decreased | 59 | 4.1 | 4.1 | signal |
| 52 | Gastroenteritis Viral | 10 | 4.1 | 4.1 | signal |
| 53 | Pulmonary Arterial Hypertension | 8 | 4.0 | 4.1 | signal |
| 54 | Dysstasia | 16 | 4.0 | 4.0 | signal |
| 55 | Laboratory Test Abnormal | 16 | 4.0 | 4.0 | signal |
| 56 | Skin Ulcer | 14 | 4.0 | 4.0 | signal |
| 57 | Hip Fracture | 17 | 3.9 | 3.9 | signal |
| 58 | Red Blood Cell Count Decreased | 15 | 3.9 | 3.9 | signal |
| 59 | Lower Limb Fracture | 10 | 3.9 | 3.9 | signal |
| 60 | Musculoskeletal Discomfort | 9 | 3.9 | 3.9 | signal |
| 61 | Metastases To Lung | 6 | 3.8 | 3.8 | signal |
| 62 | Device Occlusion | 7 | 3.7 | 3.7 | signal |
| 63 | Myoclonus | 6 | 3.7 | 3.7 | signal |
| 64 | Fall | 165 | 3.7 | 3.8 | signal |
| 65 | Thrombosis | 40 | 3.7 | 3.7 | signal |
| 66 | Spinal Operation | 6 | 3.7 | 3.7 | signal |
| 67 | Back Disorder | 8 | 3.6 | 3.6 | signal |
| 68 | Secretion Discharge | 6 | 3.6 | 3.6 | signal |
| 69 | Muscle Spasticity | 6 | 3.6 | 3.6 | signal |
| 70 | Intestinal Obstruction | 18 | 3.5 | 3.6 | signal |
| 71 | Hallucination | 36 | 3.5 | 3.6 | signal |
| 72 | Hereditary Angioedema | 5 | 3.5 | 3.5 | signal |
| 73 | Head Injury | 15 | 3.5 | 3.5 | signal |
| 74 | Wound | 13 | 3.4 | 3.5 | signal |
| 75 | Haemorrhage Intracranial | 7 | 3.4 | 3.4 | signal |
| 76 | Breast Cancer Metastatic | 5 | 3.4 | 3.4 | signal |
| 77 | White Blood Cell Count Decreased | 50 | 3.4 | 3.4 | signal |
| 78 | Bedridden | 6 | 3.4 | 3.4 | signal |
| 79 | Gastrointestinal Pain | 5 | 3.4 | 3.4 | signal |
| 80 | Product Use Complaint | 7 | 3.3 | 3.3 | signal |
| 81 | Procedural Pain | 12 | 3.2 | 3.2 | signal |
| 82 | Oral Discomfort | 6 | 3.2 | 3.2 | signal |
| 83 | Hallucination, Visual | 9 | 3.2 | 3.2 | signal |
| 84 | Metastases To Bone | 7 | 3.2 | 3.2 | signal |
| 85 | Cytopenia | 5 | 3.1 | 3.1 | signal |
| 86 | Illness | 42 | 3.1 | 3.1 | signal |
| 87 | Myelodysplastic Syndrome | 6 | 3.1 | 3.1 | signal |
| 88 | Fluid Retention | 21 | 3.0 | 3.1 | signal |
| 89 | Knee Operation | 4 | 3.0 | 3.0 | no signal |
| 90 | Oropharyngeal Pain | 38 | 3.0 | 3.1 | signal |
| 91 | Glossodynia | 9 | 3.0 | 3.0 | signal |
| 92 | Malignant Neoplasm Progression | 41 | 3.0 | 3.0 | signal |
| 93 | Cyst | 5 | 3.0 | 3.0 | signal |
| 94 | Prescribed Underdose | 8 | 3.0 | 3.0 | signal |
| 95 | Ageusia | 10 | 2.9 | 3.0 | signal |
| 96 | Therapy Partial Responder | 6 | 2.9 | 2.9 | signal |
| 97 | Complication Associated With Device | 5 | 2.8 | 2.8 | signal |
| 98 | Anhedonia | 10 | 2.8 | 2.8 | signal |
| 99 | Therapy Interrupted | 26 | 2.8 | 2.8 | signal |
| 100 | Pharyngitis Streptococcal | 4 | 2.7 | 2.7 | no signal |
| 101 | Musculoskeletal Disorder | 7 | 2.7 | 2.7 | signal |
| 102 | Fistula | 4 | 2.6 | 2.6 | no signal |
| 103 | Device Dislocation | 15 | 2.5 | 2.6 | signal |
| 104 | Metastases To Liver | 6 | 2.5 | 2.5 | signal |
| 105 | Palmar-plantar Erythrodysaesthesia Syndrome | 8 | 2.5 | 2.5 | signal |
| 106 | Product Dose Omission In Error | 9 | 2.5 | 2.5 | signal |
| 107 | No Therapeutic Response | 4 | 2.4 | 2.4 | no signal |
| 108 | Sickle Cell Anaemia With Crisis | 5 | 2.3 | 2.3 | no signal |
| 109 | Hospitalisation | 48 | 2.3 | 2.3 | signal |
| 110 | Metastases To Central Nervous System | 4 | 2.3 | 2.3 | no signal |
| 111 | Incorrect Product Administration Duration | 6 | 2.2 | 2.2 | no signal |
| 112 | Euphoric Mood | 3 | 2.1 | 2.1 | no signal |
| 113 | Product Dose Omission | 18 | 2.0 | 2.0 | signal |
| 114 | Acute Myeloid Leukaemia | 4 | 1.9 | 1.9 | no signal |
| 115 | Neoplasm Progression | 9 | 1.9 | 1.9 | no signal |
| 116 | Abnormal Weight Gain | 3 | 1.8 | 1.8 | no signal |
| 117 | Anorexia | 3 | 1.7 | 1.7 | no signal |
| 118 | Hair Texture Abnormal | 3 | 1.6 | 1.6 | no signal |
| 119 | Application Site Rash | 3 | 1.6 | 1.6 | no signal |
| 120 | Device Failure | 3 | 1.5 | 1.5 | no signal |
| 121 | Bone Loss | 3 | 1.5 | 1.5 | no signal |
| 122 | Extra Dose Administered | 7 | 1.3 | 1.3 | no signal |
| 123 | Device Issue | 15 | 1.3 | 1.3 | no signal |
| 124 | Device Leakage | 6 | 1.0 | 1.0 | no signal |
| 125 | Exposure Via Skin Contact | 3 | 1.0 | 1.0 | no signal |
| 126 | Device Breakage | 4 | 0.7 | 0.7 | no signal |